Published Articles

Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A.

J Clin Oncol. 2013 Jan 1;31(1):65-72. doi: 10.1200/JCO.2011.41.0639.

Metastasis to paranasal sinuses and orbita of breast cancer with a rare metachronous tumor of the uterine cervix.

Atasoy BM, Cetin IA, Bozkurt SU, Turhal NS.

J Craniofac Surg. 2013 Jan;24(1):e64-5. doi: 10.1097/SCS.0b013e3182700748.

Ozgen Z, Ozden S, Dane F, Atasoy BM, Akgun Z, Yumuk PF.

Hepatogastroenterology. 2013 May;60(123):533-7.

Students meeting with caregivers of cancer patient: results of an experience-based learning project.

Atasoy BM, Sarikaya O, Kuscu MK, Yondem M, Buyukkara E, Eken EG, Kahyaoglu F.

J Cancer Educ. 2012 Dec;27(4):656-63. doi: 10.1007/s13187-012-0387-3.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R; Nordic Clinical Brain Tumour Study Group (NCBTSG).

Lancet Oncol. 2012 Sep;13(9):916-26. Epub 2012 Aug 8.

Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

Basaran G, Devrim C, Caglar HB, Gulluoglu B, Kaya H, Seber S, Korkmaz T, Telli F, Kocak M, Dane F, Yumuk FP, Turhal SN.

Med Oncol. 2011 Sep;28(3):726-32. doi: 10.1007/s12032-010-9516-1.

Information for decision making by patients with early-stage prostate cancer: a comparison across 9 countries.

Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacioglu U, Gawkowska-Suwinska M, van Gils F, Heyda A, Igdem S, Macias V, Grillo IM, Moynihan C, Pijls-Johannesma M, Parker C, Pimentel N, Wördehoff H.

Med Decis Making. 2011 Sep-Oct;31(5):754-66. doi: 10.1177/0272989X10395029. Epub 2011 Jan 27.

F-18 FDG PET/CT findings of primary sinonasal hemangiopericytoma: rare location in a young adult patient.

Aras M, Dede F, Ones T, Atasoy BM, Inanir S, Erdil TY, Turoglu HT.

Clin Nucl Med. 2011 Jun;36(6):473-4. doi: 10.1097/RLU.0b013e31820ade57.

Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer.

Atasoy BM, Dane F, Uçüncü Kefelı A, Cağlar H, Cıngı A, Turhal NS, Abacioğlu U, Yeğen C.

Turk J Gastroenterol. 2011 Feb;22(1):60-4.

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP.

J Clin Oncol. 2011 Jan 10;29(2):134-41. doi: 10.1200/JCO.2010.30.1655. Epub 2010 Nov 1.

The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy.

Atasoy BM, Yonal O, Demirel B, Dane F, Yilmaz Y, Kalayci C, Abacioglu U, Imeryuz N.

Eur Arch Otorhinolaryngol. 2012 Jan;269(1):275-82. doi: 10.1007/s00405-010-1477-7. Epub 2011 Apr 7.

Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma.

Abacioglu U, Caglar HB, Yumuk PF, Akgun Z, Atasoy BM, Sengoz M.

J Neurooncol. 2011 Jul;103(3):585-93. doi: 10.1007/s11060-010-0423-2. Epub 2010 Sep 29.

Pulmonary toxicity in patients receiving docetaxel chemotherapy.

Yumuk PF, Kefeli U, Ceyhan B, Dane F, Eroglu BT, Gumus M, Cabuk D, Basaran G, Abacioglu U, Turhal NS.

Med Oncol. 2010 Dec;27(4):1381-8. doi: 10.1007/s12032-009-9391-9

Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors.

Abacioglu U, Caglar H, Atasoy BM, Abdulloev T, Akgun Z, Kilic T.

J BUON. 2010 Apr-Jun;15(2):274-80.

Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study.

Nguyen TD, Azria D, Brochon D, Poortmans P, Miller RC, Scandolaro L, Majewski W, Krengli M, Abacioglu U, Moretti L, Villa S, Akyol F, Jovenin N.

Crit Rev Oncol Hematol. 2010 Apr;74(1):66-71. doi: 10.1016/j.critrevonc.2009.04.004

T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology?

Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U.

Kulak Burun Bogaz Ihtis Derg. 2010 Mar-Apr;20(2):89-96.

Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications.

Toktas ZO, Bicer A, Demirci G, Pazarli H, Abacioglu U, Peker S, Kilic T.

J Clin Neurosci. 2010 Apr;17(4):441-5. doi: 10.1016/j.jocn.2009.08.004

Gamma knife radiosurgery for the treatment of glomus jugulare tumors.

Genç A, Bicer A, Abacioglu U, Peker S, Pamir MN, Kilic T.

J Neurooncol. 2010 Mar;97(1):101-8. doi: 10.1007/s11060-009-0002-6

Information needs of early-stage prostate cancer patients: a comparison of nine countries.

Radiother Oncol. 2010 Mar;94(3):328-33. doi: 10.1016/j.radonc.2009.12.038.

Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation.

Igdem S, Abacioglu U, Cetin I, Alco G, Akgun Z, Sengoz M, Bekiroglu N, Turkan S, Okkan S.

J BUON. 2009 Oct-Dec;14(4):629-34.

Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network.

Stein ME, Bernstein Z, Abacioglu U, Sengoz M, Miller RC, Meirovitz A, Zouhair A, Freixa SV, Poortmans PH, Ash R, Kuten A.

Am J Med Sci. 2008 Dec;336(6):478-88. doi: 10.1097/MAJ.0b013e3181731e58.

Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.

Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, Tokatli F, Agaoglu F, Zincircioglu B, Atasoy BM, Ozseker N, Yersal O, Niang U, Haydaroglu A; Turkish Oncology Group-Sarcoma Working Party.

Am J Hematol. 2008 Sep;83(9):702-7. doi: 10.1002/ajh.21211.

Trimodality treatment of malignant pleural mesothelioma.

Batirel HF, Metintas M, Caglar HB, Yildizeli B, Lacin T, Bostanci K, Akgul AG, Evman S, Yuksel M.

J Thorac Oncol. 2008 May;3(5):499-504. doi: 10.1097/JTO.0b013e31816fca1b.

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A; Rare Cancer Network.

Gynecol Oncol. 2008 Feb;108(2):298-305.

Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.

Atasoy BM, Dane F, Yumuk PF, Akgün Z, Turhal NS, Abacioğlu U, Sengöz M.

J BUON. 2008 Jan-Mar;13(1):43-50.

Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.

Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal S, Sengoz M.

J BUON. 2007 Apr-Jun;12(2):203-8.

Hodgkin's disease in the nasopharynx.

Atasoy BM, Abacioğlu U, Oztürk O, Ozdemir R, Tecimer T.

J BUON. 2006 Oct-Dec;11(4):529-31.

Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.

Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL.

Radiother Oncol. 2006 Oct;81(1):39-46.

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.

Omlin A, Amichetti M, Azria D, Cole BF, Fourneret P, Poortmans P, Naehrig D, Miller RC, Krengli M, Gutierrez Miguelez C, Morgan D, Goldberg H, Scandolaro L, Gastelblum P, Ozsahin M, Dohr D, Christie D, Oppitz U, Abacioglu U, Gruber G.

Lancet Oncol. 2006 Aug;7(8):652-6.

Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.

Weber DC, Miller RC, Villà S, Hanssens P, Baumert BG, Castadot P, Varlet P, Abacioglu U, Igdem S, Szutowicz E, Nishioka H, Hofer S, Rutz HP, Ozsahin M, Taghian A, Mirimanoff RO.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):179-86.

Gamma knife radiosurgery for cavernous sinus plasmacytoma in a patient with breast cancer history.

Peker S, Abacioğlu U, Bayrakli F, Kiliç T, Pamir MN.

Surg Neurol. 2005 Feb;63(2):174-6;

Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.

Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hiçsönmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioğlu U, Demiral AN, Hayran M.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1347-53.

Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.

Bentzen SM, Atasoy BM, Daley FM, Dische S, Richman PI, Saunders MI, Trott KR, Wilson GD.

J Clin Oncol. 2005 Aug 20;23(24):5560-7.

Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.

Abacioglu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS.

BMC Cancer. 2005 Jul 6;5:71.

Does the incidence of anal canal cancers differ in Moslem societies?

Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS.

Int J Colorectal Dis. 2005 Jan;20(1):76.

Integration of a problem-based multidisciplinary clinical cancer management course into undergraduate education.

Abacioglu U, Sarikaya O, Iskit S, Sengoz M.